Sort
141,003 grants matching “cytokine”
Neuroinflammation Maladapts Cardio Respiratory Circuits and Patterns
$683,373Frank Joseph Jacono · Case Western Reserve University · R01 · FY2022 · HL
Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease
$683,306Amanda M Brandow · Medical College Of Wisconsin · R01 · FY2022 · HL
Elastic, Degradable Vascular Grafts with Helical Microfibers
$683,293Yadong Wang · Cornell University · R01 · FY2022 · HL
Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio
$683,292Connie Schmaljohn · Geneva Foundation · R01 · FY2015 · AI
Randomized Trial of Rosiglitazone for Ulcerative Colitis
$683,283University Of Pennsylvania · R01 · FY2001 · DK
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
$683,274David M. Lewinsohn · Oregon Health & Science University · R01 · FY2021 · AI
The Impact of Tolerance in the Newborn on Lentiviral Infection
$683,272Joseph M McCune · University Of California, San Francisco · R01 · FY2013 · AI
The development of a recombinant vaccine against human onchocerciasis
$683,255Sara Lustigman · New York Blood Center · R01 · FY2019 · AI
Efficacy and immune effects of anakinra prophylaxis for neurologic toxicity and cytokine release syndrome in patients with lymphoma receiving axicabtagene ciloleucel
$683,255Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2023 · CA
Efficacy and immune effects of anakinra prophylaxis for neurologic toxicity and cytokine release syndrome in patients with lymphoma receiving axicabtagene ciloleucel
$683,255Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2022 · CA
Third-party âoff the shelfâ mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT
$683,230Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2019 · HL
Development of a Recombinant Tetravalent Dengue Vaccine Based on a Subunit Envelo
$683,222Ge Liu · Vaxinnate Corporation · R01 · FY2014 · AI
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$683,213Vaccine Research Institute Of San Diego · R01 · FY2004 · AI
Determinants of Olfactory Dysfunction in Chronic Rhinosinusitis
$683,191Timothy L Smith · Oregon Health & Science University · R01 · FY2016 · DC
Perinatal Risk of Asthma in Infants of Asthmatic Mothers
$683,161Yale University · R01 · FY2003 · AI
Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms
$683,150Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2022 · HL
Enhancing Treg Therapeutic Efficacy in GVHD
$683,148Bruce R. Blazar · University Of Minnesota · R01 · FY2025 · HL
The role of TGFbeta in development and function of salivary gland innate lymphoid cells
$683,136Marco Colonna · Washington University · R01 · FY2021 · DE
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ
$683,130Swati Kulkarni · Northwestern University At Chicago · R01 · FY2020 · CA
The joint environment and periprosthetic joint infection
$683,063Noreen J Hickok · Thomas Jefferson University · R01 · FY2023 · AR
B and Tfh cell dynamics underlying durable antibody responses to flu vaccine in children
$683,050Harinder Singh · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AI
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection
$683,045Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2017 · DA
Trial of Vitamins in HIV Progression and Transmission
$683,010Wafaie W Fawzi · Harvard School Of Public Health · R01 · FY2006 · HD
Elucidating the Role of Regulatory T cells in Establishing and Maintaining a Th2 Niche in Skin
$682,917Michael David Rosenblum · University Of California, San Francisco · R01 · FY2024 · AR
Effect of sex hormones on HIV infection of cervical and rectal mucosal tissue
$682,895Natalia Teleshova · Population Council · R01 · FY2015 · AI